Three makers of Type 2 diabetes drug Metformin announced recalls Friday, the U.S. Food & Drug Administration reported. The reason for the voluntary recalls: the U.S. Food & Drug Administration ...
Teva Pharmaceuticals USA, Inc. is voluntarily recalling fourteen (14) lots of Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 750 mg, 100 and 1000 count bottles, in the United States ...
LINCOLNSHIRE, Ill., November 1, 2005 – Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus met TM (pioglitazone HCl and metformin HCl) is now available by prescription in ...
The Drugs Controller General of India (DCGI) has informed the drug controllers of states and Union Territories that the antidiabetic fixed dose combination (FDC) of voglibose 0.2 mg and metformin Hcl ...
Metformin HCl 500 mg; extended-release tabs. Glumetza extended-release tablets are designed to deliver metformin HCl to the upper GI tract, which may reduce GI side effects often seen with ...
Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...
Granules Pharmaceuticals, Inc., Chantilly, VA is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback